Eric Sinn

Background

About Eric Sinn

Eric Sinn is a patent attorney from an academic background bridging scientific research and intellectual property law. Admitted to practice in Virginia, New York, and before the USPTO, Eric has built a distinguished career managing complex patent portfolios across biotechnology, pharmaceuticals, RNA therapeutics, stem cell therapies, and medical devices. His extensive legal expertise includes global patent prosecution, strategic IP counseling, licensing negotiations, due diligence, and infringement avoidance strategies. Eric has represented leading multinational corporations, providing comprehensive counsel in patent strategy, freedom-to-operate analyses, and competitive patent landscape assessments. Eric holds a Ph.D. in Genetics from Harvard Medical School, where he notably contributed to pioneering cancer research, including the development of the "Harvard Mouse," the first patented animal. His scientific work is widely recognized with multiple publications in prestigious journals such as Cell, Science, Nature, and the Proceedings of the National Academy of Sciences. Following his postdoctoral research in biochemistry at Rockefeller University and obtaining his Juris Doctor from Georgetown University Law Center, Eric transitioned to patent law, combining his deep scientific acumen with legal excellence to effectively support innovation and protect intellectual property in the life sciences sector.